Trial · NCT00675584
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Rate of Exacerbations Requiring Systemic Corticosteroids | Measured during the 12-month follow-up period | The rate of exacerbations was calculated as the number of exacerbations requiring prednisone per years of follow-up |
| Secondary | Proportion of Episode-free Days | Measured during the 12-month follow-up period | An episode-free day consisted of no asthma symptoms and no asthma rescue medications |
| Secondary | Number of Urgent Care Visits, Emergency Department Visits, or Hospitalizations for Wheezing or Asthma Per 12 Months | Measured during the 12-month follow-up period | |
| Secondary | Number of Participants With Treatment Failure | Measured during the 12-month follow-up period | Treatment failure was defined as the occurrence of at least one of the following events: 1. four courses of systemic corticosteroids 2. one hospitalization for acute exacerbation of wheezing 3. hypoxic seizure during an acute exacerbation of asthma/wheezing 4. intubation for acute asthma/wheezing 5. serious adverse event related to a study medication 6. physician discretion with specific rationale |
| Secondary | Change Between 12 Months and Baseline in Exhaled Nitric Oxide (eNO) | baseline and 12 months | Exhaled nitric oxide (eNO) is measured in parts per billion, and the change constructed between 12 months and baseline |
| Secondary | Change Between 12 Months and Baseline in Pulmonary Reactance and Resistance Measured Via Oscillometry | baseline and 12 months | |
| Secondary | Adverse Events Associated With Corticosteroid Use | Measured during the 12-month follow-up period | |
| Secondary | Number of Days of Absence From Daycare and Preschool for the Child and From Work for the Caregiver Per 12 Months | Measured during the 12-month follow-up period | |
| Secondary | Proportion of Days With Rescue Albuterol Use | Measured during the 12-month follow-up period | |
| Secondary | Change in Wheeze Severity During a Respiratory Tract Illness | Measured during the first seven days for each respiratory tract illness | Wheeze severity is scored as 0 (none) to 5 (very severe) during a respiratory tract illness |
| Secondary | Change Between 12 Months and Baseline in the Caregiver Quality-of-life | baseline and 12 months | The caregiver quality-of-life questionnaire consists of seven questions, each scored from 0 (worse) to 3 (best), and all seven questions are summed to yield a total score ranging from 0 to 21 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00675584/registered